The growth of the Alzheimer's Disease Therapeutics Market is directly influenced by the increasing prevalence of Alzheimer's disease globally. The hi ...

The ‘NLRP3 inflammasome’ is like a control switch. In Alzheimer’s disease, its activation triggers an inflammatory response ...

Yet, he uses patent sensationalism to promote his book, with monikers of “amyloid mafia,” “cabal,” and “Church of the Holy Amyloid.” The hypocrisy is profound. Finally an essay on the ...

A Potential Solution for Neurodegenerative Diseases. Open Access Library Journal, 12, 1-16. doi: 10.4236/oalib.1112714 . Alzheimer’s Disease (AD), a complex neurodegenerative condition, significantly ...

Combining analysis of amyloid self-assembly kinetics, biophysical characterization of monomer and fibril binding, and cryo-EM of the assembly products, we show that YX-I-1 and canagliflozin target ...

The phase 3 LUCIDITY trial of tau aggregation inhibitor hydromethylthionine mesylate ... of Alzheimer's visible in the brain, along with amyloid plaques. TauRx says it will file for approval ...

When given as an intravenous bolus, immediate and full platelet inhibition of ADP-induced platelet aggregation was observed. The clinical efficacy and safety of elinogrel will be further evaluated ...

At the JPM Healthcare conference last month, Idorsia's chief executive, Jean-Paul Clozel, presented phase 2 data with platelet aggregation inhibitor selatogrel, saying it has the potential to ...

Yusuf Hamied Department of Chemistry, University of Cambridge, Lensfield Road, Cambridge CB2 1EW, U.K.

Gestational diabetes is a common condition in which a person’s blood glucose (sugar) increases during pregnancy. While there are factors that can increase the risk of gestational diabetes—like having ...